NCT00244556View on ClinicalTrials.gov

Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Methotrexate plus ENBREL or ENBREL alone

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00244556 - Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy | Biotech Hunter | Biotech Hunter